VeriMomБезопасен ли cymbopogon citratus leaf extract oxidized при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
Related ingredients
Frequently asked questions
- Безопасен ли cymbopogon citratus leaf extract oxidized при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
- Безопасен ли cymbopogon citratus leaf extract oxidized при грудном вскармливании?
- No evidence of reproductive or lactation-specific toxicity for this ingredient in authoritative assessments. Systemic transfer into breastmilk is theoretical but not demonstrated for this extract; exposure scored as low (1) given potential for low systemic absorption of volatile constituents with topical use. Sources: ECHA Annex VI, PubChem, CosIng, PubMed (no specific studies).
- Безопасен ли cymbopogon citratus leaf extract oxidized для кожи малыша?
- No infant-specific toxicity data were found and no harmonised reproductive/ developmental classification applies. Because infant skin has higher permeability and surface-area-to-weight ratio and lemongrass extracts can contain absorbable volatile constituents (e.g., citral), exposure was increased by +1 for 0–3 yr (adult exposure low → infant moderate). Note: primary concern for topical use is skin sensitization (citral), not documented developmental toxicity for this extract. Sources: CosIng, PubChem, PubMed, EWG, ECHA (no harmonised classification).
- Как VeriMom оценивает cymbopogon citratus leaf extract oxidized?
- VeriMom оценивает cymbopogon citratus leaf extract oxidized в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы cymbopogon citratus leaf extract oxidized при беременности?
- См. наш список безопасных альтернатив cymbopogon citratus leaf extract oxidized с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.